Difference between revisions of "2009 Group 4 Project"

From CellBiology
Line 51: Line 51:
* [http://www.ncbi.nlm.nih.gov/sites/entrez / Wiesmuller.L.,Wittinghofer.F., “Signal Transduction pathways involving Ras. Mini Review”.Cellular Signalling.1994;6(3) 247-267.]
* [http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T0C-487KGHR-1&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=689b009e3a2ab218b5ba9b7f4620625e / Harvey, J. and Ashford, M.L.J. “Leptin in the CNS: much more than a satiety signal”. Neuropharmacology. 2003;44, 845-854.]
* [http://www.ncbi.nlm.nih.gov/pubmed/12676795?ordinalpos=&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.SmartSearch&log$=citationsensor / Huang EJ, Reichardt LF. “Trk receptors: roles in neuronal signal transduction”. Annu Rev Biochem. 2003;72:609-42.]
* [http://www.nature.com/onc/journal/v19/n56/abs/1204146a.html / Sebti S.M,. Hamilton A.D,. “Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies”. Oncogene.(2000).19(56): 6584-93.]
* [http://www.ncbi.nlm.nih.gov/pubmed/10395327?ordinalpos=&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.SmartSearch&log$=citationsensor / Sebolt J.S,. Dudley D.T,. Herrera.R, Van Becelaere.K, Wiland A, Gowan RC, Tecle H, Barrett SD, Bridges A, Przybranowski.S,. Leopold WR. Saltiel A.R,. “Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo”. Nat Med. (1999).5(7): 810-6.]
* [http://www.ncbi.nlm.nih.gov/sites/entrez / Kohl N.E., Omer C.A., Conner MW., Anthony NJ, Davide JP, deSolms SJ, Giuliani EA, Gomez RP., Graham SL., Hamilton K., “Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice”. Nat Med (1995).1(8): 792-7.]
* [http://www.ncbi.nlm.nih.gov/pubmed/11544482?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum / Watson FL, Heerssen HM, Bhattacharyya A, Klesse L, Lin MZ, Segal RA.“Neurotrophins use the Erk5 pathway to mediate a retrograde survival response”.Nat Neurosci.2001;4(10):981-8]
* [http://www.ncbi.nlm.nih.gov/pubmed/11114734?ordinalpos=&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.SmartSearch&log$=citationsensor/Robinson DR, Wu YM, Lin SF. The protein tyrosine kinase family of the human genome. Oncogene. 2000;19(49):5548-57.]
* [http://www.ncbi.nlm.nih.gov/pubmed/11114734?ordinalpos=&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.SmartSearch&log$=citationsensor/Robinson DR, Wu YM, Lin SF. The protein tyrosine kinase family of the human genome. Oncogene. 2000;19(49):5548-57.]
Line 57: Line 71:
* [http://www.ncbi.nlm.nih.gov/pubmed/12676795?ordinalpos=&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.SmartSearch&log$=citationsensor/Huang EJ, Reichardt LF. Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem. 2003;72:609-42.]
* [http://www.ncbi.nlm.nih.gov/pubmed/12676795?ordinalpos=&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.SmartSearch&log$=citationsensor/Huang EJ, Reichardt LF. Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem. 2003;72:609-42.]

Revision as of 11:31, 20 May 2009

'"Tropomyosin-receptor-Kinase (Trk)"'

                                       "Under construction"


The tropomyosin-receptor kinase (trk) belongs to the family of tyrosine-protein kinase receptors (TK), which was discovered as a proto-oncogene that consisted of seven exons of ‘non-muscle tropomyosin’ gene fused to the cytoplasmic domains of a novel ‘tyrosine-kinase’ gene. Trks are commonly associated with cell survival, proliferation, neurite growth including axons & dendrites as well as regulatory function of ion channels and neurotransmitter receptors in immature neural cells. In addition, binding of ligands to trks can affect growth, plasticity and synaptic strength of neuronal junctions in the adult nervous system (ref), although it is notable that Ligand binding does not itself illicit an action potential event. Three trk genes have been identified in mammals: trkA (proto-oncogene), which serves as an NGF receptor, trkB and trkC, that each was subsequently identified due to their high homology to trkA(ref).

--Hamid/Arash Araghi 08:39, 14 May 2009 (EST)


  • Trk receptors are made of an extracellular segment that binds polypeptide ligands, transmembrane helix, and cytoplasmic segment where the tyrosine kinase catalytic activity takes place.
  • The extracellular segment of the Trk receptors has various range of distinct globular domains. They include immunoglobulin-like domains, fibronectin type III-like domains, cysteine rich domains, and epidermal growth factor-like domains.

Seven subfamilies of receptor tyrosine kinases

Each of the seven subfamilies are distinct in their own ways. Please see discussion. Include the above under this heading or make a new heading for it.

--Serkan Erkan 17:12, 2 May 2009 (EST)

  • TrK receptors act as dimeric transmembrane proteins. Distally, three cysteine-rich motiffs and two Leucine rich regions form a conserved NGF binding region which is common to all TrK's near the amino terminus(in addition, TrkA is possesed of an additional NGF binding region, see TrK A).
  • Additionally, the common binding region is flanked by a pair of extracellular immunoglobulin-like domains located proximally to the cell membrane. The juxtamembrane complex contains a variable amino acid sequence suggested to determine ligand bindng affinity and specificity and may bind directly to some ligands; The localization of these peptides appears to be non-specific in tertiary NGF-TrKA complex structures however their conformation within this complex appears to indicate direct participation in complex binding.
  • Further NGF binding site affinity is generated through collaboration with the p75 protein/neurotrophin receptor (p75NTR). Furthermore, p75NTR regulates NT-3-TrkA and NT-4/5-TrkB mediated receptor activation by blocking Neurotropin ligation by circumnavigating the prequisite of these neurotropins for receptor activation.


***Tyrosine receptor kinases*** play an important role in number of fundamental cellular processes such as cell migration, cell cycle, cell metabolism and survival as well as cell proliferation and differentiation. The activation of the tyrosine receptor kinases requires two processes: enhancement of intrinsic catalytic activity and creation of binding sites to recruit downstream signaling proteins. They are both achieved by the autophosphorylation of the tyrosine residues, a consequence of ligand-mediated oligomerisation. Upon their activation, tyrosine receptor kinases transduce extracellular signals to cytoplasm by autophosphorylation of the tyrosine residues on the receptors themselves and downstream signaling proteins within the cells. --Serkan Erkan 16:45, 2 May 2009 (EST)

Maintenance and Proliferation of undifferentiated Cell Lines

Dynamic Process

NGF binding to ligation region facilitates dimerisation of Trk Receptor monomers into the signal tranductive unit- activating the kinase unit. Phosphorylation of the autoregulatory loop tyrosines of the cytoplasmic domain further activates the kinase. Phosphorylation of an additional seven tyrosines within this region promotes signalling by providing docking sides for adaptor proteins which regulate signalling-cascade couples.

Current Research


explain TrK Nomenclature



  • Autophosphorylation is the term used to define the phosphorylation of a kinase protein catalysed by its own enzymatic activity.
  • GTPases are a large family of enzymes that can bind and hydrolyse guanosine triphosphate(GTP).
  • NGF-Nerve growth Factor.
  • Exons-Expressed regions of eukaryotic genes.
  • Ras- small G-proteins that belong to the superfamily of monomeric GTPases. They are involved in receptor-mediated signal transduction pathways.
  • BDNF- Brain-derived neurotrophic growth factor is a protein that promotes activation of tropomyosine receptor kinases (trk).
  • NGF- Nerve growth factor is a protein that promotes activation of tropomyosine receptor kinases (trk).
  • Phosphorylation- A process by which a phosphate group is added to a protein that is required for its cellular activation.
  • ERK- Extracellular regulated kinase.
  • Apoptosis- Programmed cell death.
  • Farnesyl transferase inhibitors- a class of experimental cancer drug blocks farnesylation of Ras proteins.
  • Neurofibromatosis (NF)- an inherited disorder that causes production of benign tumours on nerve tissues. There are two types of NF; NF1 and NF2. NF1 is the most common disease amongst infants, also known as Recklinghausen disease.
  • Dynamin- GTPase enzyme responsible for endocytosis in eukaryotic cells.

2009 Group Projects

--Mark Hill 14:02, 19 March 2009 (EST) Please leave these links to all group projects at the bottom of your project page.

Group 1 Meiosis | Group 2 Cell Death - Apoptosis | Group 3 Cell Division | Group 4 Trk Receptors | Group 5 The Cell Cycle | Group 6 Golgi Apparatus | Group 7 Mitochondria | Group 8 Cell Death - Necrosis | Group 9 Nucleus | Group 10 Cell Shape